Sabir khan | Epidemiology | Best Researcher Award

Published on by Cell Biologist

Dr. Sabir khan | Epidemiology | Best Researcher Award

Jinfeng Laboratory, Chongqing | China

Dr. Sabir Khan’s research focuses on transcription factors, gene expression regulation, and the biosynthetic pathways of antibiotics. His work integrates microbiology and synthetic biology to explore the molecular mechanisms underlying fungal and bacterial diseases. He has contributed significantly to understanding antifungal susceptibility and the development of resistance mechanisms in pathogenic microorganisms. In addition, his studies on glioma (brain cancer) investigate microbial interactions and secondary metabolites that may offer therapeutic potential. His research extends to fermentation technology, optimizing microbial processes for enhanced antibiotic production. Dr. Khan’s postdoctoral research emphasizes ecological and synthetic biology approaches to manipulate microbial pathways for improved biosynthetic yields. By combining molecular genetics, microbiological assays, and bioinformatics tools, his work aims to identify regulatory networks and transcriptional controls involved in secondary metabolite production. Through this multidisciplinary approach, Dr. Khan contributes to the advancement of microbial biotechnology and the development of novel antimicrobial and anticancer strategies.

Profiles: Google Scholar | Orcid

Featured Publications: 

Khan, S., Bilal, H., Khan, M. N., Fang, W., Chang, W., Yin, B., Song, N. J., et al. (2024). Interleukin inhibitors and associated risk of candidiasis. Frontiers in Immunology, 28 March 2024.

Khan, S., Bilal, H., Shafiq, M., Zhang, D., Awais, M., Chen, C., Khan, M. N., et al. (2024). Distribution of Aspergillus species and risk factors for Aspergillosis from mainland China: A systematic analysis. Therapeutic Advances in Infectious Disease, 17 April 2024. https://doi.org/10.1177/2049936124xxxxx
(IF: 5.7)

Khan, S., Xu, X., Song, J., Wu, P., Liu, X., Liu, J., Chen, K., Xu, Z., Wu, H., & Zhang, B. (2022). Crosstalk of TetR-like regulator SACE_4839 and a nitrogen regulator for erythromycin biosynthesis. Applied Microbiology and Biotechnology, 106, 12345–12356.

Liu, Y.#, Khan, S.#, Wu, P.#, Liu, L., Li, B., Ni, J., Zhang, H., Chen, K., Wu, H., & Zhang, B. (2021). Uncovering and engineering mini-regulatory network of the TetR-family regulator SACE_0303 for yield improvement of erythromycin in Saccharopolyspora erythraea. Frontiers in Bioengineering and Biotechnology, 9, 715234.

Khan, S.†, Cai, L.†, Bilal, H., Khan, M. N., Fang, W., Zhang, D., & Yao, F. (2023). An 11-year retrospective analysis of candidiasis epidemiology, risk factors, and antifungal susceptibility in a tertiary care hospital in China. Scientific Reports, 13, 5678.

Khan, S.†, Hou, B., Khan, M. N., Shafiq, M., Cai, L.†, Fang, W., Wang, Q., Bilal, H., & Zeng, Y. (2025). A three-year retrospective analysis of microbial species and key biomarkers associated with wound infections in Shantou Hospital, China. Frontiers in Cellular and Infection Microbiology, 15, 15456.

Khan, S., Hameed, M. F., Zafar, I., Bibi, R., Mohany, M., Nazir, S., Kamal, M. A., & Shafiq, M. (2024). Synthesis, characterization, and pharmacological evaluation of Zn4O(BDC)3: Anticancer, antidiabetic, and drug delivery potential. Medicinal Chemistry, 20(3), 145–157.

Kambiz Akbari Noghabi | Cellular & Molecular Microbiology | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Kambiz Akbari Noghabi | Cellular & Molecular Microbiology | Best Researcher Award

National Institute of Genetic Engineering and Biotechnology (NIGEB) | Iran

Dr. Kambiz Akbari Noghabi’s research focuses on environmental and industrial biotechnology, with a strong emphasis on microbial physiology, molecular biology, and bio-nanotechnology. His work explores the cellular and molecular mechanisms underlying microbial adaptation, biopolymer production, and natural product biosynthesis. He has made significant contributions to the study of cold-induced biopolymers, particularly from Pseudomonas fluorescens, investigating their structural characteristics and potential environmental applications. His research integrates environmental microbiology with biotechnology to develop sustainable bioprocesses for pollution control, waste management, and bioremediation. Dr. Noghabi also investigates microbial natural products and antimicrobial peptides (AMPs), focusing on their isolation, biochemical and molecular characterization, and functional applications. His multidisciplinary approach combines enrichment and isolation techniques, molecular typing, spectrophotometric analyses, and taxonomical methods to identify and engineer microbial strains with industrial and environmental potential. Overall, his studies contribute to advancing eco-friendly microbial technologies and the development of biologically derived materials for industrial and environmental innovations.

Profiles: Google Scholar | Orcid

Featured Publications:

Talaee, M., Modiri, S., Rajabi, M., Saadati, F., Akbari, A., Javadi, S., Guo, S., Vali, H., & Akbari Noghabi, K. (2025). Selective toxicity of a novel antimicrobial peptide Acidocin 4356 against Pseudomonas aeruginosa and Acinetobacter baumannii in human cell-based in-vitro infection models. Scientific Reports, 15, 2450.

Mohseni Sani, N., Talaee, M., Saadati, F., Ashoori, F., Zamani, J., Shahbani Zahiri, H., Vali, H., & Akbari Noghabi, K. (2025). NT‐OmpA bioemulsifier: Structural insights and polysaccharide‐mediated enhancement of its emulsifying performance. ChemPlusChem, e202400774.

Razani, S., Pourbaferani, M., Mahmoodian, S., Tarrahimofard, H., Ahmadian, G., & Akbari Noghabi, K. (2025). A peek into the relationship between probiotic characteristics of Lactiplantibacillus plantarum strains and Sortase A gene expression. Current Microbiology, 82, 356.

Fakouri, A., Ghorbani, N., Shafiei, M., Mahmodifard, M., & Akbari Noghabi, K. (2025). Natural-synthetic hybrid nanoparticles: Polydopamine-Phycocyanin composites for enhanced antibacterial phototherapy against bacterial pathogens. Journal of Photochemistry & Photobiology B: Biology. Accepted.

Yi Zhang | Tumor Immunology | Best Researcher Award

Published on by Cell Biologist

Prof. Yi Zhang | Tumor Immunology | Best Researcher Award

The First Affiliated Hospital of Zhengzhou University | China

Prof. Yi Zhang is a globally recognized leader in genetically engineered cell therapy and translational immuno-oncology research. Over the past 36 years, he has made pioneering contributions to overcoming major barriers in cell therapy and advancing its clinical applications worldwide. His extensive research has produced 290 SCI-indexed publications, including 11 ESI top 1% highly cited papers, accumulating more than 14,000 citations and an h-index of 66. Prof. Zhang’s groundbreaking innovations include identifying the novel CAR-T therapeutic target CD276 for solid tumors, developing gene-editing technologies to reduce PD-1–mediated immunosuppression, and creating novel cytokines and culture protocols that enhance immune cell stemness and anti-tumor function. He has also led the development of CAR-T cells that normalize tumor vasculature and improve infiltration, significantly enhancing therapeutic efficacy. With 46 invention patents (17 authorized) and over 80 million yuan in technology transfers, his work bridges basic science and clinical application through an integrated “industry-university-research” platform. As principal investigator, he has directed more than 52 clinical trials—29 targeting solid tumors, the highest number globally—resulting in improved outcomes and even clinical cures for advanced cancer patients. His leadership in establishing national standards and safety protocols has also shaped the regulation and global best practices in cell therapy.

Profile: Orcid

Featured Publications:

Gao, Y., Liu, S., Huang, Y., Wang, H., Zhao, Y., Cui, X., Peng, Y., Li, F., & Zhang, Y. (2024, December 3). CAR T cells engineered to secrete IFNκ induce tumor ferroptosis via an IFNAR/STAT1/ACSL4 axis. Cancer Immunology Research.

Huang, Y., Cao, R., Wang, S., Chen, X., Ping, Y., & Zhang, Y. (2025, December 31). In vivo CAR-T cell therapy: New breakthroughs for cell-based tumor immunotherapy. Human Vaccines & Immunotherapeutics.

Li, J., Wang, D., Zhang, Z., Sun, K., Lei, Q., Zhao, X., Huang, J., Wang, L., & Zhang, Y. (2025, June 1). Serum carcinoembryonic antigen levels as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with colorectal cancer. The Journal of Immunology.

Lian, J., Yue, Y., Yu, W., & Zhang, Y. (2025, March 5). Correction: Immunosenescence: A key player in cancer development. Journal of Hematology & Oncology.

Ping, Y., Fan, Q., & Zhang, Y. (2025, February). Modulating lipid metabolism improves tumor immunotherapy. Journal for ImmunoTherapy of Cancer.

Hu, W., Li, F., Liang, Y., Liu, S., Wang, S., Shen, C., Zhao, Y., Wang, H., & Zhang, Y. (2025, January). Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid tumors. Journal for ImmunoTherapy of Cancer.

Marwa Aly | Bacterial Extracellular Vesicles | Best Researcher Award

Published on by Cell Biologist

Dr. Marwa Aly | Bacterial Extracellular Vesicles | Best Researcher Award

Dr. Marwa Aly | HB Fuller | United States

Dr. Marwa Aly (published as Marwa Gamal Saad), Ph.D., is a Senior Scientist at H.B. Fuller Company with an impressive interdisciplinary background spanning microbiology, bioengineering, nanotechnology, and biotechnology. She holds dual Ph.D. degrees from Port Said University (with research at Texas A&M University) and Washington State University, where she recently completed a thesis on bacterial extracellular vesicles targeting drug-resistant pathogens. Dr. Aly has authored multiple high-impact publications, secured substantial research funding, and contributed to patent-pending technologies. Her innovative work bridges the gap between microbial research and real-world applications, such as alternative biofuels and novel antimicrobials. With an h-index of 6 and over 250 citations, she has demonstrated consistent scientific impact. Recognized by prestigious awards like the Cougar Cage Award and WSU President’s Leadership Award, Dr. Aly is an emerging thought leader in microbial biotechnology, making her a prime candidate for the Best Researcher Award.

Publication Profiles:

Google Scholar
Scopus
Orcid

Education:

Dr. Marwa Aly holds two Doctor of Philosophy degrees in advanced scientific disciplines. She earned her first Ph.D. in Botany from Port Said University, Egypt, with collaborative research at Texas A&M University, USA. Her research focused on sustainable biofuel production from microalgae using nanotechnology and genetic engineering. She recently completed a second Ph.D. in Engineering from Washington State University, USA. Her dissertation investigated bacterial extracellular vesicles and their potential as next-generation antimicrobials against drug-resistant pathogens. Dr. Aly’s dual doctoral qualifications reflect her interdisciplinary expertise and commitment to solving complex global challenges. Her educational journey is marked by innovation, academic rigor, and successful translation of research into real-world impact.

Research Experience:

As a Graduate Assistant at Washington State University in Dr. Wen-Ji Dong’s Lab, Dr. Aly has pioneered research on microbial extracellular vesicles (EVs), securing a provisional patent and winning $100,000 in Cougar Cage funding. Her work involves in vitro and in vivo analysis of EVs from Pseudomonas aeruginosa, exploring their antimicrobial action, especially against Candida auris and drug-resistant pathogens. She also studies the role of ferroptosis in EV-mediated treatment strategies and has led proteomic profiling of bacterial biofilms. In her earlier Ph.D. work, she developed methods for microalgae-based biodiesel production using advanced microfluidics and nanotechnology. Her multidisciplinary research blends microbiology, chemical engineering, and biotechnology to address critical challenges in public health and sustainable energy. Her scientific contributions are recognized globally, making her a strong contender for research excellence.

Awards and Honors:

Dr. Marwa Aly has received multiple prestigious accolades recognizing her leadership, innovation, and research excellence. She was a winner of the ISEV Image Competition, celebrating creativity in extracellular vesicle research. She received the Cougar Cage Award from Washington State University for her promising EV-based antimicrobial proposal. Her leadership and academic excellence earned her the WSU President’s Award for Leadership and recognition as a WSU Woman of Distinction. These awards highlight not only her scientific contributions but also her dedication to community engagement, mentorship, and cross-disciplinary collaboration. Her ability to secure competitive funding, publish impactful research, and innovate at the intersection of biology and engineering underscores her qualifications for the Best Researcher Award.

Research Focus:

Dr. Marwa Aly’s research centers on extracellular vesicles (EVs) and their potential to combat antimicrobial resistance. Her recent focus is on stage-dependent EVs produced by Pseudomonas aeruginosa and algae, exploring their ability to disrupt biofilms and trigger ferroptosis in pathogenic organisms. Her research includes proteomic analysis, biofilm interaction studies, and in vivo wound infection models, advancing the understanding of EVs as therapeutic agents. Additionally, she has conducted microfluidic-based studies for biofuel optimization, developing innovative devices to study microalgae growth under various environmental conditions. Her work is grounded in translational science, bridging lab discoveries with industrial applications such as bioenergy and infection control. By integrating microbiology, bioengineering, and nanotech, she is at the forefront of next-generation biotechnologies, making substantial contributions to public health, sustainability, and microbial sciences.

Publications Top Notes:

  1. Algal Biofuels: Current Status and Key Challenges – Energies

  2. Exosomes as Powerful Engines in Cancer: Isolation, Characterization and Detection Techniques – Biosensors

  3. Evaluation of Storage Stability for Biocrude Derived from Hydrothermal Liquefaction of Microalgae – Energy & Fuels

  4. High-Throughput Screening of Chlorella Vulgaris Growth Kinetics in Microfluidics – Biomolecules

  5. Droplet-based Microfluidic Gradient for Chlorella Growth under Nitrogen & Temp Stress – Algal Research

  6. Impact of Nitrogen Regime on Fatty Acid Profiles of Algae for Biofuel – Acta Botanica Hungarica

  7. Dual Roles of Conditional Extracellular Vesicles from Pseudomonas Biofilms – Biofilm

  8. Phytochemical Screening and Antimicrobial Activity of Egyptian Green Algae – Journal of Medicinal Plants Studies

  9. Nitrogen Concentration Impact on Algal Biomass, Lipids & Biofuel Yield – IJSTR

  10. Challenges of Biodiesel Production from Oscillatoria sp. – IJAR

Conclusion:

In conclusion, Dr. Marwa Aly (Marwa Gamal Saad) is a highly qualified, driven, and impactful researcher who has made significant contributions across several vital scientific areas, from microbial therapeutics to renewable biofuels. Her dual-Ph.D. credentials, publication record, patent-pending research, competitive grant success, and multiple recognitions make her an excellent candidate for the Best Researcher Award. While she can further enhance her profile through increased international engagement and publication output, her current achievements already distinguish her as a rising leader in the fields of biotechnology, microbiology, and bioengineering. She is not only suitable but highly recommended for this recognition.

Raphael Borie | Gene Regulation Epigenetics | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Raphael Borie | Gene Regulation Epigenetics | Best Researcher Award

Prof. Dr. Raphael Borie, APHP, France

Dr. Raphaël Borie, born on August 15, 1977, in Paris, France, is a leading expert in pulmonology and genetic respiratory diseases. Currently a University Professor Hospital Practitioner at Bichat Hospital (Paris Cité University), he has consistently contributed to the advancement of respiratory medicine, particularly in the field of interstitial lung diseases (ILDs). His clinical insight, combined with a strong research portfolio, has positioned him as a prominent figure within the OrphaLung network. A dedicated family man with two children, Dr. Borie is widely respected for his integrity, leadership, and commitment to collaborative medicine. His career reflects a unique blend of academic excellence and impactful translational research, bridging the gap between genomics and clinical care in ILD. He is a registered member of the French Medical Council (Ordre des Médecins No. 75/71138), and his research has influenced European clinical guidelines and improved the understanding of rare genetic pulmonary conditions.

Publication Profile: 

Scopus

✅ Strengths for the Award:

  1. Robust Academic Background:
    Dr. Borie holds a PhD in Genetics, Master’s in Physiology, and HDR (habilitation to supervise doctoral research), which underlines his scientific credibility and ability to lead independent research.

  2. Clinical-Research Integration:
    As a University Professor and Hospital Practitioner, he merges frontline patient care with cutting-edge genetic and respiratory disease research.

  3. High Publication Impact:
    With 283 PubMed-indexed articles and an H-index of 60, Dr. Borie’s work demonstrates strong citation influence, indicating widespread recognition and utility in the scientific community.

  4. International Leadership:
    Active in multinational collaborations (e.g., OrphaLung, ERS), he has co-authored major position statements and clinical trials, influencing European respiratory care guidelines.

  5. Innovation in Rare Diseases:
    A recognized expert in familial interstitial lung disease and telomere disorders, his work has led to earlier diagnosis and targeted therapies—critical in fields where few experts exist.

  6. Recognition and Funding:
    He has secured prestigious mobility grants (ERS, Respirology Teachers College)—a marker of trust in his scientific mission and innovation.

🔍 Areas for Improvement:

  • Wider Public Health Translation: While Dr. Borie’s genomic research is exceptional, expanding into real-world health policy implementation could enhance systemic impact.

  • Patient Engagement & Advocacy: Developing patient-oriented tools or registries (e.g., digital apps or platforms for familial lung diseases) may broaden his outreach beyond academia and clinics.

  • Broader Visibility: Although highly cited in professional circles, participation in international keynote talks, editorial leadership, or mainstream health media could elevate his public and professional visibility.

🎓 Education:

Dr. Borie has pursued an extensive and rigorous academic path focused on respiratory and genetic medicine. He obtained his medical degree with specialization in Allergology and Immunopathology in 2006. A year earlier, in 2005, he earned a Master’s degree in Biology and Physiology of Circulation and Respiration. Demonstrating deep interest in genetics, he completed a PhD in Genetics in 2017, contributing significantly to our understanding of genetic underpinnings in pulmonary fibrosis. In 2019, Dr. Borie achieved the prestigious Habilitation à Diriger des Recherches (HDR) from the University of Paris 7, enabling him to supervise doctoral research. His academic background illustrates a powerful integration of clinical expertise and molecular research—providing him with the tools to lead innovative research projects at the intersection of genomics and pulmonology.

🩺 Experience:

Dr. Raphaël Borie has over 15 years of experience in respiratory medicine. From July 2011 to August 2020, he served as a Hospital Practitioner in the Pneumology Department at Bichat Hospital under Professors Aubier and Crestani. Since September 2020, he has been a University Professor Hospital Practitioner in the same department, affiliated with Paris Cité University. He has contributed to patient care, education of medical students and residents, and cutting-edge research. As part of the OrphaLung network, he plays a critical role in advancing diagnostic tools and treatment approaches for rare lung diseases. He is recognized for his collaborative leadership and interdisciplinary contributions across genetics, immunology, and pulmonology. His international collaborations and authorship of over 280 PubMed-indexed publications demonstrate his ongoing commitment to improving patient outcomes through translational research.

🏆 Awards and Honors:

Dr. Borie’s research excellence has been recognized through several prestigious awards and scholarships. In 2017, he received the European Respiratory Society (ERS) Mobility Grant for his work on Identification of Preclinical Markers of Pulmonary Fibrosis, supporting international collaboration and advanced training. The same year, he was also honored with the Respirology Teachers College Mobility Grant, reinforcing his pioneering research on early detection of fibrotic lung disease. His selection for these awards highlights both scientific innovation and dedication to knowledge exchange. His leadership in multi-center studies and involvement in ERS guideline statements further reflect his status as a thought leader in interstitial lung disease. These honors are a testament to his influence in shaping the future of pulmonary genetics and translational respiratory medicine.

🔬 Research Focus:

Dr. Raphaël Borie’s research centers on familial and genetic interstitial lung diseases, particularly the molecular mechanisms behind pulmonary fibrosis, telomere biology, surfactant-related gene variants, and early detection strategies. He works extensively on identifying genetic risk variants (e.g., MUC5B, DSP) and their implications in idiopathic pulmonary fibrosis. Through his participation in the OrphaLung network, he supports genomic screening for hereditary lung disorders and contributes to developing European guidelines. His work bridges genomic medicine and clinical pulmonology, aiming for earlier diagnosis and personalized treatment approaches. He has led and co-authored critical studies on RTEL1 mutations, telomerase complex defects, and familial ILD phenotypes, helping clinicians globally understand the heterogeneity and systemic implications of genetic lung disorders. His collaborative international research ensures his findings are applied in practice to optimize long-term patient care.

📚Publications Top Notes:

  • 🧬 High risk of lung cancer in surfactant-related gene variant carriers – Eur Respir J, 2024

  • 📄 European Respiratory Society Statement on Familial Pulmonary Fibrosis – Eur Respir J, 2022

  • 🧪 Colocalization of Gene Expression and DNA Methylation with Genetic Risk Variants – Am J Respir Crit Care Med, 2022

  • 🧬 RTEL1 mutations and their phenotypic variability – Eur Respir J, 2019

  • 💊 Safety and efficacy of pirfenidone in telomerase mutation carriers – Eur Respir J, 2018

  • 🌐 Diagnosis and follow-up of familial ILD: International survey – BMC Pulmonary Med, 2025

  • 🧬 New 2023 ACR/EULAR APS criteria performance in young patients – Letter, 2025

  • 🫁 A non-resolving cough: a case of familial pulmonary fibrosis – Breathe, 2025

  • 🧬 PFMG2025: Genomic medicine in French healthcare system – Review, 2025

  • 💊 Efficacy of CFTR modulators in ABCA3-deficiency ILD – Open Access, 2025

  • 🧠 Neurological manifestations in VEXAS syndrome – Journal of Neurology, 2025

  • 💉 Real-life use of PEXIVAS reduced-dose regimen in vasculitis – Ann Rheum Dis, 2025

  • 🧫 Recurrent respiratory papillomatosis with lung involvement – Eur Respir J, 2025

  • 🔍 RA-ILD: genetics to clinical overview – Review, 2025

  • 👶 Childhood ILD survivors in adulthood: European study – Eur Respir J, 2025

🧾 Conclusion:

Dr. Raphaël Borie exemplifies the ideal candidate for the Best Researcher Award. His excellence spans across clinical expertise, academic distinction, and international research leadership, especially in genetic and familial interstitial lung diseases—a field with enormous unmet need. His consistent scholarly output, impactful collaborations, and patient-focused studies highlight a unique blend of depth and innovation. While further expansion into public health frameworks and patient engagement tools would be valuable, his profile already reflects a world-class researcher with transformative contributions to pulmonary medicine.

Mahedi Hasan | Plasma Medicine | Young Researcher Award

Published on by Cell Biologist

Mr. Mahedi Hasan | Plasma Medicine | Young Researcher Award

Mr. Mahedi Hasan, Shizuoka University, Japan

Mahedi Hasan is a promising Bangladeshi researcher with a strong academic and research foundation in genetic engineering and nanostructured optoelectronics. Currently pursuing his PhD at Shizuoka University, Japan, his work bridges plasma science with biomedical applications, focusing on cold atmospheric microplasma for drug delivery and cellular modulation. Previously, Mahedi completed his BS and MS in Genetic Engineering and Biotechnology from the University of Rajshahi with excellent academic distinction. He has published extensively in international peer-reviewed journals, collaborating with multinational research teams in Japan and Bangladesh. His passion lies in innovative, interdisciplinary approaches to solving complex biomedical problems, with a vision to improve targeted therapeutics. Mahedi has demonstrated remarkable dedication, from assisting in molecular biology labs to leading pioneering plasma-based biomedical research. With an emerging global presence and deep scientific curiosity, Mahedi Hasan is an ideal candidate for the Young Researcher Award.

Publication Profile: 

Orcid

✅ Strengths for the Award:

  1. Robust Academic Foundation

    • Strong academic performance in both undergraduate (CGPA 3.63) and postgraduate (CGPA 3.87) studies in Genetic Engineering & Biotechnology.

    • Currently pursuing a PhD in Optoelectronics and Nanostructure Science at a reputable Japanese institution (Shizuoka University), indicating a cross-disciplinary research approach.

  2. High-Impact Research Contributions

    • Authored 10+ peer-reviewed publications, several in Q1 journals, addressing cutting-edge topics such as cold atmospheric plasma (CAP), drug delivery, and cellular senescence.

    • Demonstrated innovation in plasma-assisted biomedical applications, including nose-to-brain delivery systems and BBB penetration strategies.

  3. International Collaboration and Experience

    • Collaborates with an international team across Bangladesh and Japan, engaging in complex projects with global relevance.

    • Ongoing research in Japan exposes him to high-end lab infrastructure and interdisciplinary training.

  4. Recognitions and Scholarships

    • Winner of the National Science and Technology (NST) Fellowship – 2019, a significant national-level endorsement of research potential.

    • Recipient of the Graduate Board Scholarship – 2019 for academic excellence.

  5. Consistent Research Focus

    • Maintains a clear research trajectory from plant plasma applications to nanotechnology and plasma-driven biomedical interventions, showcasing a deepening specialization.

🧩 Areas for Improvement:

  1. Independent Project Leadership

    • Most publications are collaborative; demonstrating leadership in principal investigator (PI)-style roles or initiating independent proposals would further establish his research autonomy.

  2. Wider Conference Participation

    • Engaging more frequently in international conferences and symposiums (oral/poster presentations) would enhance visibility and networking.

  3. Diversification of Funding Sources

    • Beyond national scholarships, pursuing international research fellowships (e.g., JSPS, DAAD, Marie Skłodowska-Curie) would show strategic initiative and grant-writing skills.

  4. Industrial/Clinical Relevance Expansion

    • Potential to link his plasma-based research with real-world medical or commercial applications through translational or industry-collaborative projects.

📘 Education:

Mahedi Hasan’s academic journey showcases consistent excellence. He is currently pursuing a Ph.D. in Optoelectronics and Nanostructure Science at Shizuoka University, Japan (2023–ongoing), where his research focuses on cold plasma-mediated drug delivery systems. He holds both Bachelor’s (2018) and Master’s (2019) degrees in Genetic Engineering and Biotechnology from the University of Rajshahi, Bangladesh. Despite delays in examination schedules, he graduated with distinction, securing a CGPA of 3.87/4.00 in MS and 3.63/4.00 in BSc. His academic records demonstrate a strong foundation in life sciences, biotechnology, and interdisciplinary research. Through his studies, he developed expertise in molecular biology, protein science, and advanced biomedical technologies. His transition into nanostructured optoelectronics further highlights his adaptability and commitment to advancing next-generation therapeutic technologies. Mahedi’s education reflects not only academic brilliance but also his progressive shift toward impactful, translational science.

🧪 Experience:

Mahedi Hasan has garnered substantial research experience across molecular biology and plasma-based therapeutics. He served as a Research Assistant at the

Apply now for the Plasma Medicine Research for Young Researcher Award—honoring early-career scientists advancing plasma technology in medicine. Open to researchers under 35. Submit your abstract and supporting documents today!

& Protein Science Lab in the Department of Genetic Engineering & Biotechnology, University of Rajshahi, from May 2019 to September 2023. His role included evaluating the effects of low-pressure dielectric barrier discharge (LPDBD) plasma on the growth, physiology, and nutritional properties of crops like wheat and maize. Prior to that, he completed a Research Internship in the same lab, where he explored the impact of LFGD plasma on agronomic and nutritional traits. His current Ph.D. research continues this trajectory, now exploring cold atmospheric microplasma for improved drug absorption across the blood-brain barrier and in cancer cells. Mahedi’s experience demonstrates a unique blend of plant and human model systems, bench-to-bedside translation, and strong interdisciplinary collaboration in both Bangladeshi and Japanese labs.

🏅 Awards and Honors:

Mahedi Hasan’s research potential has been recognized with several prestigious awards. In 2019, he received the National Science and Technology (NST) Fellowship from the Ministry of Science and Technology, Government of Bangladesh, a competitive award supporting emerging scientific talent. That same year, he was honored with the Graduate Board Scholarship by the University of Rajshahi, granted for his academic excellence during his Master’s studies. These accolades highlight his academic brilliance and commitment to impactful research. His continuous involvement in high-impact international collaborations and publications in reputable journals further solidify his reputation as a dedicated young scientist. As a Ph.D. candidate in Japan, he continues to contribute to frontier biomedical applications of microplasma technology. These honors, coupled with his impressive research output and global collaborations, make him an outstanding contender for any young researcher recognition.

🔬 Research Focus:

Mahedi Hasan’s research uniquely bridges biotechnology, plasma physics, and nanomedicine. His core focus is on the application of cold atmospheric microplasma in enhancing drug delivery, especially across complex barriers like the blood-brain barrier and into cancerous cells. His work explores microplasma-assisted nose-to-brain delivery systems, cellular senescence modulation, and targeted uptake of hydrophilic compounds. His research employs both cellular (in vitro) and animal (in vivo) models to study absorption efficiency, molecular interaction, and bioavailability of therapeutic agents. In his early work, he investigated plasma’s role in altering the physiology and nutritional value of crops. Now, through cutting-edge interdisciplinary collaborations at Shizuoka University, he is working at the frontier of plasma-assisted biomedical innovation, opening new doors for non-invasive drug delivery systems. This fusion of bioscience with physical sciences represents a novel, transformative approach, making his research both timely and globally significant.

📚 Publications Top Notes:

  1. 📄 Microplasma-Mediated Enhancement of FD-150 Uptake in HL-60 Cells

  2. 🧠 Absorption of FD-150 in Brain Endothelial Cells by Cold Atmospheric Microplasma

  3. 🧬 Exploring the Role of Microplasma for Controlling Cellular Senescence in Saccharomyces cerevisiae

  4. ⚡ Voltage Dependent Effect of Spiral Wound Plasma Discharge on DBC1.2 Cellular Integrity

  5. 🧪 Enhancing Galantamine Distribution in Rat Brain Using Microplasma-Assisted Nose-to-Brain Drug Delivery

  6. 🧫 Absorption of FD-150 into White Blood Cells by Microplasma

  7. 🚧 In Vitro Drug Delivery through the Blood–Brain Barrier Using Cold Atmospheric Plasma

  8. 🧼 Lipidomics of Microplasma-Irradiated Cells at Optimized Discharge Conditions for Absorption of High-Molecule Drug

  9. 🐍 Toxins Profiles and Histological Impact of Trimeresurus erythrurus Venom: In Vitro and In Vivo Study

  10. 🧯 Evaluation of Bungarus caeruleus Venom and Antivenom Efficacy Used in Bangladesh

📝 Conclusion:

Mahedi Hasan emerges as a highly promising young researcher with a multidisciplinary profile rooted in biotechnology, plasma science, and nanostructure-based drug delivery systems. His solid academic background, commendable publication record, and international research involvement make him a strong contender for the Young Researcher Award. While he could benefit from taking on greater research leadership and wider dissemination of his work, his achievements to date clearly indicate excellent potential for impactful scientific contributions in the coming years.

Abdulatif AL-Haj | Cytoskeleton Cell Motility | Innovative Research Award

Published on by Cell Biologist

Dr. Abdulatif AL-Haj | Cytoskeleton Cell Motility | Innovative Research Award

Dr. Abdulatif AL-Haj | Ruhr Universität Bochum | Germany

Dr. Abdulatif Al Haj is a highly accomplished biochemist and molecular cardiology researcher originally from Syria, currently residing in Germany. With extensive academic and professional experience across Europe and the Middle East, Dr. Al Haj has built a multidisciplinary career in molecular biology, biotechnology, and medical education. He holds a doctorate in biology and biotechnology, with a strong focus on actin dynamics and cardiovascular disease. Fluent in Arabic, German, English, and French, he has effectively bridged scientific research with public health, education, and social integration roles. His work includes teaching, paramedic service during the pandemic, and involvement in migrant integration and healthcare initiatives. He has contributed to peer-reviewed publications and collaborated with notable researchers in Germany. Dr. Al Haj exemplifies international scientific cooperation and interdisciplinary application of biosciences for societal benefit.

publication profile:

scopus

🔍 Strengths for the Award:

  • 🔬 Cutting-Edge Research: Key discoveries in actin cytoskeleton regulation and thymosin beta4′s role in cardiac repair

  • 🌍 Global Impact: Extensive collaborations in Germany and Syria, advancing both education and research

  • 📚 Scientific Output: Author of multiple high-impact journal articles and presenter in international scientific symposia

  • 👨‍🏫 Cross-disciplinary Excellence: Combines life sciences, education, and healthcare

  • 🧪 Innovative Thinking: Integrated research on cofilin/ADF, Arp2/3 complex, and cardiomyocyte remodeling

🚧 Areas for Improvement:

  • Broader dissemination of findings through more international conferences

  • Increase involvement in grant-funded principal investigator (PI) roles

  • Enhance digital presence via scientific networking platforms (e.g., ResearchGate, ORCID)

🎓 Education :

Dr. Al Haj earned his diploma and Master’s degrees in Biotechnology and Biochemistry from the University of Damascus, Syria. He later completed a Doctorate in Biology and Biotechnology with a dissertation on the modulation of cofilin/ADF and thymosin beta4 in cell migration. His academic pursuits also include studies in Educational Planning, Natural Sciences, and Microbiology at the Technical University of Applied Sciences Berlin and Ruhr University Bochum. Additionally, he undertook postgraduate training in Education and Psychology, Business English, and quality management under TÜV-certified programs. Dr. Al Haj further enriched his academic repertoire with continuous professional development courses in process management, norm standards (ISO 9001), and nutrition. His commitment to lifelong learning reflects a passion for combining theoretical science with applied clinical and educational practices.

🧪 Experience :

Dr. Al Haj has accumulated extensive research and teaching experience across several prestigious institutions. At the Ruhr University Bochum, he worked with Prof. Hans Georg Mannherz on actin-regulating proteins, contributing to innovative cardiology research. He held posts at Catholic and Central Clinics as a scientist, served as a paramedic at Herne Vaccination Center, and worked as a social worker and integration coach. His academic duties included teaching biology, chemistry, and physics, and serving as an Arabic language teacher in Berlin. Additionally, Dr. Al Haj took on project management and quality assurance roles at LVQ Further Education gGmbH and underwent TÜV training for process management. His unique blend of clinical, educational, and social service roles highlights his commitment to interdisciplinary collaboration and societal contribution.

🔬 Research Focus :

Dr. Al Haj’s research centers on molecular and experimental cardiology, cytoskeletal proteins (cofilin/ADF), and cell migration. His doctoral and postdoctoral work explored the effects of thymosin beta4 and actin-regulating proteins on cellular motility—essential for understanding cardiac development and cancer metastasis. His published work includes significant studies on the Arp2/3 complex, actin dynamics, and the influence of sGC activators on cardiac cells from hypertensive and heart failure patients. Beyond molecular cardiology, he has explored radioimmunoassay techniques, EBV-associated gastric carcinoma, and embryological development of cardiac muscle from branchial arch progenitors. His multidisciplinary approach blends biochemistry, histology, anatomy, and clinical diagnostics, bridging basic research with therapeutic applications. His ongoing interest in student assessment and e-learning underscores a commitment to scientific education and training.

📚 Publications Top Notes :

  1. 🧬 Inhibition of Arp2/3 Complex after ADP-Ribosylation of Arp2 by Binary Clostridioides Toxins – Cells, 2022

  2. ❤️ sGC Activator Causes Beneficial Remodeling in Cardiomyocytes from Hypertensive Rats and Heart Failure Patients – Front. Physiol.

  3. 🧠 Chicken Second Branchial Arch Progenitor Cells Contribute to Heart Musculature In Vitro and In Vivo – Developmental Dynamics, 2020

  4. 🧫 Characteristics of Gastric Carcinoma Associated with Epstein Barr Virus in Algeria – Der Pharmacia Lettre, 2017

  5. 🦴 Etiology and Pathogenesis of Arthrofibrosis at the Cellular Level – Arthroscopy, 2016

  6. 🧪 HeLa Cells and the Human Colon Carcinoma BE, 3LNLN and EB3 Cell Lines – Dissertation Work

  7. 🎓 Research on Assessing Students’ Academic Performance in Bloom’s Cognitive Level

🧾 Conclusion :

Dr. Abdulatif Al Haj is a strong candidate for the Innovative Research Award, distinguished by his relentless pursuit of molecular innovation, interdisciplinary approach, and commitment to public health and education. His work on actin-binding proteins and cardiac regeneration holds promising implications for heart disease treatment and personalized medicine. His track record demonstrates scientific creativity, rigor, and societal relevance.

SANKALP MISRA | Microbiology | Best Researcher Award

Published on by Cell Biologist

Assist. Prof. Dr. SANKALP MISRA | Microbiology | Best Researcher Award

Assist. Prof. Dr. SANKALP MISRA , Shri Ramswaroop Memorial University , India

Dr. Sankalp Misra is a dedicated microbiologist with a Ph.D. in Microbial Technology, currently working as a Research Associate at CSIR-National Botanical Research Institute (NBRI), Lucknow. Born on November 6, 1988, in India, he has cultivated a robust academic and research career focused on plant-microbe interactions and sustainable agriculture. Fluent in both English and Hindi, Dr. Misra has consistently demonstrated a commitment to addressing real-world agricultural challenges through microbiological innovations. His research explores the symbiotic relationships between soil microbes and plants, particularly under stress conditions such as salinity and drought. With a host of fellowships, awards, and scientific publications to his name, Dr. Misra is not only a prolific researcher but also a valued contributor to India’s agricultural biotechnology community. He is a life member of the Association of Microbiologists of India and continues to contribute actively to scientific dialogue and applied research in microbial ecology.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Extensive Research Experience
    Over 10 years of continuous research in microbial biotechnology, especially plant-microbe interactions, bioremediation, and stress physiology, primarily under the CSIR-NBRI—a top-tier research institution in India.

  2. Focused Scientific Contributions
    His Ph.D. work on salt-tolerant plant growth-promoting rhizobacteria (PGPR) addresses crucial agricultural challenges, with implications in sustainable farming and climate-resilient agriculture.

  3. Prolific Publication Record
    Co-authored over 15 research papers and book chapters in high-impact journals and internationally reputed publishers (Springer, Wiley, Academic Press).

  4. Nationally Recognized Fellowships & Awards

    • ICMR Research Associate & Senior Research Fellowship

    • Gold Medalist in B.Sc.

    • Multiple Best Poster Awards in national and international conferences

    • Consistent CSIR-UGC NET success (31st and 47th ranks)

  5. Professional Engagement
    Holds a Life Membership in The Association of Microbiologists of India, reflecting his active involvement in the scientific community.

  6. Interdisciplinary Expertise
    Skilled in proteomics, metagenomics, microbial ecology, and plant stress biology, showcasing an ability to tackle complex problems from multiple biological angles.

⚙️ Areas for Improvement:

  1. International Exposure
    While the research is nationally strong, global collaborations or international fellowships could further elevate the impact and visibility of his work.

  2. Grant Leadership & Independent Projects
    Leading funded projects as a Principal Investigator (PI) would demonstrate further maturity in research leadership and scientific management.

  3. Patent/Technology Transfer
    Translating research into patents, bio-formulations, or industry partnerships could bridge the lab-to-land gap, enhancing the practical application of his findings.

🎓 Education:

Dr. Sankalp Misra completed his Ph.D. in Microbial Technology from CSIR-NBRI, focusing on the “Characterization of salt tolerant plant growth promoting rhizobacteria from different agro-climatic zones of Uttar Pradesh.” Guided by Dr. Puneet Singh Chauhan, his doctoral work laid a foundation in microbial stress biology. He qualified the prestigious CSIR-UGC NET in both 2013 (47th rank) and 2014 (31st rank), showcasing strong academic competence. He also cleared the CET-Ph.D in 2012. His undergraduate studies were marked by excellence, earning a Gold Medal in B.Sc., emphasizing his early commitment to academic rigor. These achievements underline his solid foundation in microbiology, plant biology, and biotechnological research. Throughout his educational journey, Dr. Misra has consistently demonstrated a deep curiosity for microbial applications in agriculture and an aptitude for integrating advanced scientific methods to address pressing challenges in crop sustainability and soil health.

💼 Experience:

Dr. Sankalp Misra has over a decade of research experience in plant-microbe interactions. He is currently an ICMR-Research Associate at CSIR-NBRI since October 2019. Prior roles include ICMR-Senior Research Fellow and several project fellowships at CSIR-NBRI from 2013 to 2019. These positions allowed him to work on key projects involving soil microbiomes, salt and drought stress in plants, and bioremediation. His extensive hands-on experience ranges from lab-based experiments to field applications, focusing on sustainable and ecological approaches in agriculture. He has significantly contributed to the development of microbial formulations and transgenic studies aimed at improving crop resilience. His continuous association with CSIR-NBRI reflects a stable and productive research career. Each role has helped him refine his techniques in molecular biology, microbiome analysis, and biotechnological innovation, making him a competent and valuable researcher in environmental microbiology and sustainable agricultural practices.

🏅 Awards and Honors:

Dr. Misra has received multiple accolades recognizing his scientific excellence. He was awarded the prestigious ICMR Research Associateship (Oct 2019) and Senior Research Fellowship (July 2019), reflecting national-level recognition. His scientific presentations have earned him Best Poster Awards in major conferences, including the 3rd National Seminar on Life Sciences (NSCTLS-2021) and the 6th International Conference on Plants and Environmental Pollution (ICPEP-6, 2018). Academically, he secured top ranks in CSIR-UGC NET (31st in 2014 and 47th in 2013) and earned a Gold Medal in B.Sc., demonstrating exceptional merit throughout his academic and research career. His commitment is further underscored by his life membership in The Association of Microbiologists of India (AMI). These achievements highlight his consistent dedication, peer recognition, and leadership potential in the fields of microbiology and agricultural biotechnology.

🔍 Research Focus:

Dr. Sankalp Misra’s research centers on plant-microbe interactions, especially under environmental stress like salinity and drought. He explores rhizobacteria that promote plant growth and mitigate stress through mechanisms such as ACC deaminase production, metabolomic reprogramming, and soil microbial community enhancement. His interests extend to soil metagenomics, microbial proteomics, and bioremediation, all aimed at achieving sustainable agriculture. A key aspect of his work involves isolating and characterizing stress-tolerant microbes from diverse agro-climatic zones, using them to enhance crop resilience and productivity. His work contributes to global efforts in climate-resilient farming, making him a notable figure in applied agricultural microbiology. He has co-authored numerous high-impact publications and book chapters that explore these themes, confirming his deep engagement in cutting-edge microbial biotechnology.

📚 Publications Top Notes:

  1. 🌱 Enhancement of Drought Tolerance in Transgenic Arabidopsis thaliana Plants Overexpressing Chickpea Ca14-3-3 Gene

  2. 🦠 Novel trends in endophytic applications for plant disease management

  3. 🌍 Rhizobacteria‐Mediated Bioremediation: Insights and Future Perspectives

  4. 🌾 Endospheric Microbiome-Assisted Alteration in the Metabolomic Profiling of Host towards Abiotic Stress Mitigation

  5. 🧬 Revealing the complexity of protein abundance in chickpea root under drought-stress using comparative proteomics

  6. 🔬 Characterization of alkalotolerant Alcaligenes and Bacillus strains for mitigating alkaline stress in Zea mays

  7. 🌿 Drought tolerant Ochrobactrum sp. inoculation helps maintain homeostasis in Zea mays under water stress

  8. ⚗️ ACC deaminase-producing Bacillus spp. mitigate salt stress and enhance Zea mays growth

  9. 🧪 Exploration of Soil Resistome Through a Metagenomic Approach

  10. 🍃 Essential Oils: Potential Application in Disease Management

📝 Conclusion:

Dr. Sankalp Misra is an excellent and deserving candidate for the Best Researcher Award. His consistent contributions to microbial biotechnology, evidenced by a strong portfolio of peer-reviewed publications, government fellowships, and research impact, make him stand out in his field. His work is not only academically significant but also socially and environmentally relevant in addressing global issues like soil degradation, crop yield loss due to climate stress, and sustainable agriculture.

Laura Yesenia Solís Ramos | Biotecnología de plantas | Best Researcher Award

Published on by Cell Biologist

Dr Laura Yesenia  Solís Ramos | Biotecnología de plantas |  Best Researcher Award

Profesora e investigadora at  Escuela de Biología, UCR, CIBET, Costa Rica

Laura Yesenia Solís Ramos is an accomplished researcher and academic from San José, Costa Rica, currently serving as an Associate Professor at the University of Costa Rica (UCR). She holds a Ph.D. in Plant Sciences and Biotechnology from the Centro de Investigación Científica de Yucatán (CICY) in Mérida, Mexico, and a Master’s degree in Forest Ecology from the Universidad Veracruzana, Xalapa, Mexico. Her Bachelor’s degree in Forest Engineering was obtained from the Instituto Tecnológico de Costa Rica.

Profile:

📜 Academic Background:

  • Ph.D. in Plant Sciences and Biotechnology
    Centro de Investigación Científica de Yucatán (CICY), Mérida, Mexico
  • M.S. in Forest Ecology
    Instituto de Genética Forestal, Universidad Veracruzana, Mexico
  • B.Sc. in Forest Engineering
    Instituto Tecnológico de Costa Rica, Costa Rica

🔬 Research Interests:

  • Plant Biotechnology
  • Genetic Transformation of Plants
  • Molecular Biology of Plants
  • In Vitro and Ex Vitro Biotechnologies
  • Symbiotic Organisms Ecology

🛠️ Research Projects:

  1. Arbuscular Mycorrhizal Fungi in Caoba Development
  2. Biodiversity of Nitrogen-Fixing Microorganisms
  3. Characterization of Mycorrhizal Fungi in Tropical Forests

🎓 Teaching Experience:

  • Courses in Biotechnology, Bioremediation, Plant Tissue Culture, and Genetic Engineering since 2008

📈 Citation Metrics:

  • Total Citations: 296
  • Citations Since 2019: 194
  • h-index: 10 (8 since 2019)
  • i10-index: 10 (7 since 2019)

Publication Top Notes:

  1. Overexpression of WUSCHEL in C. chinense Causes Ectopic Morphogenesis
    LY Solís-Ramos, T González-Estrada, S Nahuath-Dzib, …
    Plant Cell, Tissue and Organ Culture (PCTOC) 96, 279-287, 2009
    Citations: 62
  2. Somatic Embryogenesis in Recalcitrant Plants
    LY Solís-Ramos, A Andrade-Torres, LA Sáenz-Carbonell, …
    Embryogenesis, 597-618, 2012
    Citations: 43
  3. Variación Morfométrica en Dos Poblaciones Naturales de Pinus hartwegii Lindl. del Estado de Veracruz
    LG Iglesias, LY Solís-Ramos, H Viveros-Viveros
    Phyton (Buenos Aires) 81 (2), 239-247, 2012
    Citations: 31
  4. Indirect Somatic Embryogenesis and Morphohistological Analysis in Capsicum chinense
    LY Solís-Ramos, S Nahuath-Dzib, A Andrade-Torres, F Barredo-Pool, …
    Biologia 65, 504-511, 2010
    Citations: 28
  5. Role of Arbuscular Mycorrhizal Symbiosis in Remediation of Anthropogenic Soil Pollution
    LY Solís-Ramos, C Coto-López, A Andrade-Torres
    Symbiosis 84 (3), 321-336, 2021
    Citations: 24
  6. Establishment of Cell Suspension Cultures of Two Costa Rican Jatropha Species (Euphorbiaceae)
    LY Solís-Ramos, LM Carballo, M Valdez-Melara
    Revista de Biología Tropical 61 (3), 1095-1107, 2013
    Citations: 18
  7. Genetic Diversity Analysis of Jatropha Species from Costa Rica Using AFLP Markers
    R Avendaño, S José, C Rica, EG Díaz, S José, C Rica, M Valdez-Melara, …
    American Journal of Plant Sciences 6 (14), 2426, 2015
    Citations: 15
  8. Endogenous GUS-like Activity in Capsicum chinense Jacq
    LY Solís-Ramos, T González-Estrada, A Andrade-Torres, …
    Electronic Journal of Biotechnology 13 (4), 2-3, 2010
    Citations: 12
  9. Respuesta de Plántulas de Cedrela odorata a la Inoculación con Rhizophagus intraradices y Diferentes Niveles de Defoliación
    I Oros-Ortega, A Alonso-López, J Pérez-Moreno, JC López-Collado, …
    Revista Mexicana de Ciencias Agrícolas 6 (3), 627-635, 2015
    Citations: 11
  10. Effect of Gamma Irradiation and Selection with Fungus Filtrate (Rhizoctonia solani Kuhn) on the In Vitro Culture of Common Bean (Phaseolus vulgaris)
    LY Solís-Ramos, M Valdez-Melara, R Alvarado-Barrantes, F Mora-Umaña, …
    American Journal of Plant Sciences 6 (16), 2672, 2015
    Citations: 10
  11. Agrobacterium tumefaciens-Mediated Transformation of Common Bean (Phaseolus vulgaris) var. Brunca
    LY Solís-Ramos, JC Ortiz-Pavón, A Andrade-Torres, R Porras-Murillo, …
    Revista de Biología Tropical 67 (2), 83-94, 2019
    Citations: 8
  12. Expression Analysis of Two SOMATIC EMBRYOGENESIS RECEPTOR KINASE (SERK) Genes During In Vitro Morphogenesis in Spanish Cedar (Cedrela odorata L.)
    R Porras-Murillo, A Andrade-Torres, LY Solís-Ramos
    3 Biotech 8, 1-9, 2018
    Citations: 7

 

 

 

Ahmad Sharifi | Plant Biotechnology | BioAgri Innovator Excellence Award

Published on by Cell Biologist

Assist Prof Dr Ahmad Sharifi |  Plant Biotechnology  |  BioAgri Innovator Excellence Award

Research Institute for Industrial Biotechnology, Iranian Academic Centre for Education, Culture and Research (ACECR)- Khorasan Razavi Branch at  Horticultural Plants Biotechnology Department,  Iran

Dr. Ahmad Sharifi is a dedicated faculty member at the Ornamental Plant Biotechnology Department of the Iranian Academic Center for Education, Culture & Research (ACECR). With a PhD in Agricultural Biotechnology from Ferdowsi University of Mashhad (2015), Dr. Sharifi also holds an MSc (2003) and a BSc (2000) in Agricultural Sciences from Ferdowsi University of Mashhad and the Agricultural Sciences and Natural Resources University of Gorgan, respectively.

Profile:

Academic Qualifications:

🎓 BSc: Agricultural Sciences and Natural Resources, University of Gorgan, 2000
🎓 MSc: Ferdowsi University of Mashhad, 2003
🎓 PhD: Ferdowsi University of Mashhad, 2015

 

Areas of Expertise:

🌿 Plant Biotechnology
🌱 Plant Tissue Culture

 

Research Focus: Plant Biotechnology

  • Plant Tissue Culture:
    • Development and optimization of in vitro culture techniques for ornamental plants.
    • Somatic embryogenesis and organogenesis in various plant species.
    • Micropropagation protocols for large-scale production of disease-free plants.
  • Genetic Engineering:
    • Genetic transformation methods to enhance desirable traits in ornamental plants, such as disease resistance and improved flower quality.
    • CRISPR/Cas9 and other gene-editing technologies for targeted genetic modifications.
  • Molecular Biology:
    • Analysis of gene expression patterns and molecular pathways involved in plant growth and development.
    • Use of molecular markers for plant breeding and genetic diversity studies.
  • Biotechnological Applications:
    • Production of secondary metabolites and phytochemicals through biotechnological approaches.
    • Application of biotechnology for sustainable agricultural practices and environmental conservation.
  • Bioreactor Systems:
    • Utilization of bioreactor systems for the mass propagation of ornamental plants.
    • Scaling up plant tissue culture techniques for commercial applications.

Publication Top Notes:

1. Optimization of the in-vitro culture protocol of Haworthiopsis viscosa and Haworthia truncata var. truncate

  • Authors: Kharrazi, M., Sargazi Moghaddam, Z., Moradian, M., Khadem, A., Sharifi, A.
  • Journal: South African Journal of Botany, 2024, 169, pp. 506–514

2. Micropropagation and ex vitro rooting of three ZZ plant (Zamioculcas zamiifolia Engl.) cultivars

  • Authors: Kharrazi, M., Moradian, M., Moghaddam, Z.S., Khadem, A., Sharifi, A.
  • Journal: In Vitro Cellular and Developmental Biology – Plant, 2023, 59(1), pp. 129–139

3. Role of AGAMOUS Gene in Increasing Tepals of Amaryllis

  • Authors: Dastmalchi, S., Moshtaghi, N., Sharifi, A.
  • Journal: Journal of Agricultural Science and Technology, 2023, 25(4), pp. 975–988

4. Auxin sensitivity improves production of rosmarinic acid in transformed hairy roots of Lavandula angustifolia

  • Authors: Khadem, A., Bagheri, A., Moshtaghi, N., Akhar, F.K., Sharifi, A.
  • Journal: Biological Communications, 2022, 67(3), pp. 160–167

5. In vitro propagation and callus induction of medicinal endangered plant meadow rue (Thalictrum minus L.) for producing berberine

  • Authors: Moghaddam, Z.S., Moshtaghi, N., Sharifi, A., Zahedi, A., Khadem, A.
  • Journal: Journal of Medicinal Plants, 2022, 21(81), pp. 92–101